The feasibility of procalcitonin and CPIS score to reduce inappropriate antibiotics use among severe-critically ill COVID-19 pneumonia patients: A pilot study
Description
COVID-19 pneumonia is associated with a mortality up to 20% varying by country1 with the number of global deaths over 5 million.2 Antibiotics have been extensively used in COVID-19 patients in intensive care units (ICUs) without a clear indication.3
